MED-ALLY
MED-ALLY is a privately held US medical device CDMO that designs, develops, and manufactures Class III Active Implantable Medical Devices, principally neuromodulation systems built on its proprietary VersaStim platform, for enterprise OEMs, academic researchers, and government clients.
- Company typePrivate
- Founded2011
- HeadquartersSummerville, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What MED-ALLY does
MED-ALLY (legal entity Med Ally LLC) is a privately held US medical device company founded in 2011 by Raja Hitti and John Mulvihill, headquartered in Goose Creek, South Carolina. The firm designs, develops, and manufactures Active Implantable Medical Devices (AIMDs), with a focus on neuromodulation and bioelectronic medicine. Its core technology is the proprietary VersaStim® platform, a programmable and adaptable neuromodulation architecture supporting Implantable Pulse Generators (IPGs), External Pulse Generators (EPGs), and lead systems for therapy paradigms including deep brain stimulation, spinal cord stimulation, peripheral nerve, sacral root, occipital, and trigeminal stimulation, addressing conditions such as chronic pain, incontinence, Parkinson's disease, diabetic neuropathy, epilepsy, and traumatic brain injury.
The company operates a vertically integrated manufacturing facility with a 3,000 square foot Class 7 cleanroom, hermetic enclosure welding, robotic glovebox, fine-pitch lasers, lead winders, and molding capability. It holds ISO 13485:2016 (NQA certified), FDA 21CFR820, and ISO 14971 risk management certifications. Revenue is generated through contract design, development, and manufacturing services for Class III implants under multi-year, project-based pricing with a fixed-cost manufacturing approach, plus technology licensing of VersaStim IP. Customers include enterprise OEMs (QV Bioelectronics, Sensars, Newronika, Medipace), academic research centers (USC BioMEMS, University of Pittsburgh), and government (NIH), with offshore manufacturing partnerships extending global reach. In February 2026, MED-ALLY divested select manufacturing equipment and IP to Resonetics, formalizing a strategic partnership to scale neuromodulation manufacturing capacity while the company retains focus on R&D and new product development.
MED-ALLY firmographics
Firmographics- Name
- MED-ALLY
- Legal name
- Med Ally LLC
- Website
- https://med-ally.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MED-ALLY is a privately held US medical device CDMO that designs, develops, and manufactures Class III Active Implantable Medical Devices, principally neuromodulation systems built on its proprietary VersaStim platform, for enterprise OEMs, academic researchers, and government clients.
- Ownership category
- akta.pro rank
MED-ALLY industry classification
Industry- Product category
- Active Implantable Medical Devices (Neuromodulation Manufacturing)
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)
Keywords
Where MED-ALLY is headquartered
LocationHeadquarters
- HQ city
- Summerville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
MED-ALLY business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Infrastructure, Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Contract Manufacturing Services: Manufacturing of IPG-based Class III medical implants and controllers using a fixed-cost approach to provide predictable, budget-friendly pathways for clients from development through completion.
- Design and Development Services: Comprehensive design and development resources leveraging the VersaStim platform and decades of experience to mitigate regulatory, engineering, and assembly risks, speeding up design processes for medical devices.
- Documentation and Project Management: Full Design History File (DHF) documentation and Device Master Record (DMR) with dedicated experienced Project Managers blending agile and traditional methodologies.
- Technology Licensing and IP Transfer: Licensing of VersaStim Technologies designs and related IP to strategic partners for expanded manufacturing capacity and system innovation.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
MED-ALLY product offering
Product offeringCore offering
MED-ALLY designs, develops, and manufactures Active Implantable Medical Devices (AIMDs) with a focus on neuromodulation and bioelectronic medicine. Its core offering is the proprietary VersaStim neuromodulation technology platform, which underpins Implantable Pulse Generators (IPGs), External Pulse Generators (EPGs), and supporting components for therapies including deep brain stimulation, spinal cord stimulation, and peripheral nerve stimulation. The company provides end-to-end B2B services spanning concept design, prototype development, full-scale Class III implant manufacturing in a Class 7 cleanroom, and full Design History File (DHF) and Device Master Record (DMR) documentation.
Product overview
Med-Ally operates as a manufacturer of Active Implantable Medical Devices, offering the VersaStim® neuromodulation technology platform as its core product family. The portfolio includes Implantable Pulse Generators (IPGs) and External Pulse Generators (EPGs) designed for therapies including Deep Brain Stimulation, Spinal Cord Stimulation, and other neuromodulation applications. These products are supported by design and development services, prototype development and assembly, manufacturing, and comprehensive documentation and project management services. The company serves client partners seeking to accelerate medical device development.
Differentiator
Problem solved
Functional benefit
Brands
- VersaStim: Neuromodulation technology platform for Active Implantable Medical Devices including Implantable Pulse Generators (IPGs) and External Pulse Generators (EPGs). VersaStim is a programmable and adaptable platform addressing conditions such as chronic pain, incontinence, Parkinson's, diabetic neuropathy, epilepsy, and traumatic brain injury.
Products and services
- VersaStim Neuromodulation Technology Platform A programmable and adaptable neuromodulation technology platform for Implantable Pulse Generators (IPGs) and External Pulse Generators (EPGs), supporting discrete electronics or ASIC designs, single or multiple batteries (primary or rechargeable), and various telemetry schemes for indications including chronic pain, incontinence, Parkinson's, diabetic neuropathy, epilepsy, and traumatic brain injury.
- Implantable Pulse Generators (IPGs) Class III Active Implantable Medical Devices designed for interventional therapies including Deep Brain Stimulation, Spinal Cord Stimulation, Spinal Cord Injury, Peripheral, Ganglia, Sacral Root, Occipital, Trigeminal, and Inter Fascicle paradigms, built on the VersaStim platform.
- External Pulse Generators (EPGs) External pulse generator systems supporting the VersaStim platform for medical device therapy applications, complementing the implantable IPG product family.
- Design and Development Services for Active Implantable Medical Devices Comprehensive design and development services for Active Implantable Medical Devices and their integral and peripheral components, leveraging the VersaStim platform and decades of experience to mitigate regulatory, engineering, and assembly risks.
- Implanted Medical Device Manufacturing Vertically integrated contract manufacturing of IPG-based Class III medical implants and controllers in a Class 7 cleanroom using a fixed-cost approach, ensuring reliable, repeatable outcomes with disciplined fiscal management.
- Prototype Development and Assembly Services Prototype development using high-speed and precision robotics combined with hand assemblies and IPC-qualified soldering techniques to produce consistent prototypes and final products ready for clinical work.
- Documentation and Project Management Services Full Design History File (DHF) documentation and Device Master Record (DMR) preparation with dedicated experienced project managers blending agile and traditional methodologies tailored to program needs.
Quantifiable outcome
- 18 months or less from concept to full scale manufacturing
Companies that use MED-ALLY
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles2 records
MED-ALLY technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
MED-ALLY partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- ResoneticscoreStrategic transaction where Resonetics acquired select manufacturing equipment and related IP from Med-Ally, formalizing a partnership that enables Resonetics to further its integrated solution for neuromodulation customers while continuing to support Med-Ally's production and NPD needs. The partnership enhances Med-Ally's scalability, operational resilience, and supply continuity while allowing Med-Ally to focus on research, new product development, and system innovation.
- Blue Arbor TechnologiesminorMed-Ally congratulated Blue Arbor Technologies on receiving FDA Breakthrough Device Designation for their RESTORE Neuromuscular Interface System. While not a formal commercial partnership, this represents a collaborative relationship in supporting innovative medical device development.
- Offshore Manufacturing GroupsminorStrategic partnerships and contractual commitments with offshore groups serve as transparent and cost-effective extensions of Med-Ally's operations, extending global reach.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
MED-ALLY competitors and assessment
Company assessmentDirect peers
- Resonetics: Resonetics is a medical device contract manufacturer specializing in nitinol, laser processing, and bioelectronics — including neuromodulation implants. It directly competes with Med-Ally's IPG/leads manufacturing and, after the February 2026 transaction, now owns Med-Ally's former equipment and IP.
- Cirtec Medical: Cirtec Medical is a contract manufacturer of active implantable and minimally invasive medical devices, including neuromodulation IPGs and leads. It serves the same Class III implantable CDMO customer base as Med-Ally and offers comparable design-to-manufacturing services.
- Nordson Medical: Nordson Medical provides contract manufacturing for medical devices including implantable components and precision-engineered parts used in neuromodulation systems. It directly competes for OEM design-and-build engagements similar to Med-Ally's VersaStim platform work.
- SMC Ltd. SMC Ltd. is a medical device contract manufacturer specializing in finished Class II/III devices, including electronic and implantable products. It offers design, development, and manufacturing services to OEMs in a similar profile to Med-Ally's service mix.
- Donatelle: Donatelle is a medical device contract manufacturer offering design, development, and production of Class III implantable and interventional devices. It competes for the same neuro- and cardiovascular-implant OEM customers that Med-Ally targets.
- Micro Systems Engineering (MSEI): MSEI (a Sencio/Integer affiliate historically) is a contract manufacturer specializing in active implantable medical devices including neuromodulation IPGs and pacemaker components. It is a direct peer in the AIMD CDMO space.
- Biomerics: Biomerics is a contract manufacturer of interventional and implantable medical devices with expertise in neuromodulation leads, components, and finished devices. It serves a similar OEM client base and overlaps with Med-Ally's manufacturing and design capabilities.
Broad incumbents
- Integer Holdings: Integer Holdings is a large, publicly-traded medical device contract manufacturer with capabilities in active implantable devices, neuromodulation components, and finished Class III devices. It is a much broader incumbent competing for the same OEM customers Med-Ally serves.
- Phillips-Medisize (Molex): Phillips-Medisize is a large medical CDMO with capabilities in drug delivery and combination products, including implantable and electronic medical devices. It competes for OEM contract manufacturing engagements in the Class III implant space adjacent to Med-Ally's core offering.
Others
- Verily (Alphabet) / Galvani Bioelectronics: Galvani Bioelectronics (a Verily/GSK venture) is developing bioelectronic medicines using implantable neuromodulation technology — directly adjacent to Med-Ally's customer base. While primarily a therapeutic developer, it represents the strategic end-market Med-Ally's CDMO services support.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
MED-ALLY social profiles
Digital presenceMED-ALLY compliance and trust
Trust signalCompliance4 records
MED-ALLY financial estimates
Financial estimateRevenue estimate
Valuation estimate
MED-ALLY leadership team
Management profileNumber of profiles
Profiles2 records
MED-ALLY funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MED-ALLY M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MED-ALLY
What does MED-ALLY do?
MED-ALLY designs, develops, and manufactures Active Implantable Medical Devices (AIMDs) with a focus on neuromodulation and bioelectronic medicine. Its core offering is the proprietary VersaStim neuromodulation technology platform, which underpins Implantable Pulse Generators (IPGs), External Pulse Generators (EPGs), and supporting components for therapies including deep brain stimulation, spinal cord stimulation, and peripheral nerve stimulation. The company provides end-to-end B2B services spanning concept design, prototype development, full-scale Class III implant manufacturing in a Class 7 cleanroom, and full Design History File (DHF) and Device Master Record (DMR) documentation.
Is MED-ALLY a public or private company?
MED-ALLY is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MED-ALLY founded?
MED-ALLY was founded in 2011. It employs 11 to 50 people.
Where is MED-ALLY based?
MED-ALLY is headquartered in Summerville, United States, in the North America region.
How does MED-ALLY make money?
Four revenue lines are on record. Contract Manufacturing Services are the primary driver. The others are design and Development Services, documentation and Project Management and technology Licensing and IP Transfer.
Who are MED-ALLY's main competitors?
Direct peers on record are Resonetics, Cirtec Medical, Nordson Medical, SMC Ltd., Donatelle, Micro Systems Engineering (MSEI) and Biomerics. Broad incumbents are Integer Holdings and Phillips-Medisize (Molex). Verily (Alphabet) / Galvani Bioelectronics is listed as an others.
Does MED-ALLY have an API?
No public API is recorded for MED-ALLY.
What industry is MED-ALLY in?
MED-ALLY's product category is Active Implantable Medical Devices (Neuromodulation Manufacturing). Its primary akta.pro industry code is HLAHAEAK, Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS). Its NAICS code is 334510 and its SIC code is 3845.